BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 31594213)

  • 1. Relationship between p16 expression and prognosis in different anatomic subsites of OSCC.
    Ni Y; Zhang X; Wan Y; Dun Tang K; Xiao Y; Jing Y; Song Y; Huang X; Punyadeera C; Hu Q
    Cancer Biomark; 2019; 26(3):375-383. PubMed ID: 31594213
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk stratification of early stage oral tongue cancers based on HPV status and p16 immunoexpression.
    Ramshankar V; Soundara VT; Shyamsundar V; Ramani P; Krishnamurthy A
    Asian Pac J Cancer Prev; 2014; 15(19):8351-9. PubMed ID: 25339028
    [TBL] [Abstract][Full Text] [Related]  

  • 3. p16 - a Possible Surrogate Marker for High-Risk Human Papillomaviruses in Oral Cancer?
    Sritippho T; Pongsiriwet S; Lertprasertsuke N; Buddhachat K; Sastraruji T; Iamaroon A
    Asian Pac J Cancer Prev; 2016; 17(8):4049-57. PubMed ID: 27644660
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Double Positivity for HPV DNA/P16
    Alsharif U; Hofmann M; Gebhard M; Tharun L; Rades D; Sieg P; Hakim SG
    Anticancer Res; 2021 Nov; 41(11):5557-5568. PubMed ID: 34732426
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of human papillomavirus in p16-positive oral cancers.
    Belobrov S; Cornall AM; Young RJ; Koo K; Angel C; Wiesenfeld D; Rischin D; Garland SM; McCullough M
    J Oral Pathol Med; 2018 Jan; 47(1):18-24. PubMed ID: 29024035
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Possible Role of Human Papillomavirus Infection in the prognosis of Oral Squamous Cell Carcinoma in a Northern Israel Population.
    Ghantous Y; Akrish S; Leiser Y; Abu El-Naaj I
    Isr Med Assoc J; 2018 Mar; 20(3):155-160. PubMed ID: 29527853
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detection of human papillomavirus infection in oral squamous cell carcinoma: a cohort study of Japanese patients.
    Kouketsu A; Sato I; Abe S; Oikawa M; Shimizu Y; Takahashi T; Kumamoto H
    J Oral Pathol Med; 2016 Sep; 45(8):565-72. PubMed ID: 26711722
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic value of HMGA2, P16, and HPV in oral squamous cell carcinomas.
    Loeschke S; Ohlmann AK; Bräsen JH; Holst R; Warnke PH
    J Craniomaxillofac Surg; 2016 Sep; 44(9):1422-9. PubMed ID: 27421171
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunohistochemical analysis of p16 expression, HPV infection and its prognostic utility in oral squamous cell carcinoma.
    Gröbe A; Hanken H; Kluwe L; Schöllchen M; Tribius S; Pohlenz P; Clauditz T; Grob T; Simon R; Sauter G; Heiland M; Blessmann M
    J Oral Pathol Med; 2013 Oct; 42(9):676-81. PubMed ID: 23721566
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Focal Adhesion Kinase (FAK) Overexpression and Phosphorylation in Oral Squamous Cell Carcinoma and their Clinicopathological Significance.
    Kato A; Kato K; Miyazawa H; Kobayashi H; Noguchi N; Kawashiri S
    Pathol Oncol Res; 2020 Jul; 26(3):1659-1667. PubMed ID: 31522363
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biologic importance and prognostic significance of selected clinicopathological parameters in patients with oral and oropharyngeal squamous cell carcinoma, with emphasis on smoking, protein p16(INK4a) expression, and HPV status.
    Laco J; Nekvindova J; Novakova V; Celakovsky P; Dolezalova H; Tucek L; Vosmikova H; Vosmik M; Neskudlova T; Cermakova E; Hacova M; Sobande FA; Ryska A
    Neoplasma; 2012; 59(4):398-408. PubMed ID: 22489695
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of p16-overexpression on overall and progression-free survival outcomes in oral cavity squamous cell carcinomas: A semi-national, population-based study.
    Schneider K; Jakobsen KK; Jensen JS; Wessel I; Christensen A; Specht L; Lelkaitis G; Mirian C; Buchwald CV; Grønhøj C
    Oral Oncol; 2020 Dec; 111():105031. PubMed ID: 33069060
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combined Testing of p16 Tumour-suppressor Protein and Human Papillomavirus in Patients With Oral Leukoplakia and Oral Squamous Cell Carcinoma.
    Sundberg J; Korytowska M; Burgos PM; Blomgren J; Blomstrand L; DE Lara S; Sand L; Hirsch JM; Holmberg E; Giglio D; Öhman J; Kovács A; Horal P; Lindh M; Kjeller G; Hasséus B
    Anticancer Res; 2019 Mar; 39(3):1293-1300. PubMed ID: 30842161
    [TBL] [Abstract][Full Text] [Related]  

  • 14. p16 expression independent of human papillomavirus is associated with lower stage and longer disease-free survival in oral cavity squamous cell carcinoma.
    Satgunaseelan L; Virk SA; Lum T; Gao K; Clark JR; Gupta R
    Pathology; 2016 Aug; 48(5):441-8. PubMed ID: 27370365
    [TBL] [Abstract][Full Text] [Related]  

  • 15. FKBP51 Immunohistochemical Expression: A New Prognostic Biomarker for OSCC?
    Russo D; Merolla F; Mascolo M; Ilardi G; Romano S; Varricchio S; Napolitano V; Celetti A; Postiglione L; Di Lorenzo PP; Califano L; Dell'Aversana GO; Astarita F; Romano MF; Staibano S
    Int J Mol Sci; 2017 Feb; 18(2):. PubMed ID: 28218707
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of Kif5b protein is significantly associated with the progression, recurrence and prognosis of oral squamous cell carcinoma.
    Luan YJ; Xu Y; Cai J; Dou Y; Yu WJ; Wang KT; Liu SH; Yang PS; Qu X; Wei FC
    Eur Rev Med Pharmacol Sci; 2018 Jul; 22(14):4542-4550. PubMed ID: 30058692
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High-risk HPV DNA status and p16 (INK4a) expression as prognostic markers in patients with squamous cell cancer of oral cavity and oropharynx.
    Śnietura M; Jaworska M; Pigłowski W; Goraj-Zając A; Woźniak G; Lange D
    Pol J Pathol; 2010; 61(3):133-9. PubMed ID: 21225495
    [TBL] [Abstract][Full Text] [Related]  

  • 18. KRT84 is a potential tumor suppressor and good prognosis signature of oral squamous cell carcinoma.
    Liu Y; Li R; Ren G
    Biosci Rep; 2020 Apr; 40(4):. PubMed ID: 32181476
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of the eighth TNM classification on p16-positive oropharyngeal squamous cell carcinomas in the Netherlands and the importance of additional HPV DNA testing.
    Nauta IH; Rietbergen MM; van Bokhoven AAJD; Bloemena E; Lissenberg-Witte BI; Heideman DAM; Baatenburg de Jong RJ; Brakenhoff RH; Leemans CR
    Ann Oncol; 2018 May; 29(5):1273-1279. PubMed ID: 29438466
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differences in the prognosis of HPV16-positive patients with squamous cell carcinoma of head and neck according to viral load and expression of P16.
    Biesaga B; Mucha-Małecka A; Janecka-Widła A; Kołodziej-Rzepa M; Szostek S; Słonina D; Kowalczyk A; Halaszka K; Przewoźnik M
    J Cancer Res Clin Oncol; 2018 Jan; 144(1):63-73. PubMed ID: 29043437
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.